John Overdeck’s Conformis, Inc. Common Stock CFMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,231
Closed -$138K 4744
2021
Q4
$138K Sell
7,231
-56,528
-89% -$1.45M ﹤0.01% 3999
2021
Q3
$2.12M Buy
63,759
+27,434
+76% +$967K ﹤0.01% 1933
2021
Q2
$1.04M Buy
+36,325
New +$858K ﹤0.01% 2440
2020
Q1
Sell
-1,765
Closed -$66K 4015
2019
Q4
$66K Sell
1,765
-2,109
-54% -$100K ﹤0.01% 3552
2019
Q3
$180K Buy
3,874
+370
+11% +$22.2K ﹤0.01% 3221
2019
Q2
$382K Buy
3,504
+628
+22% +$51.7K ﹤0.01% 2696
2019
Q1
$207K Sell
2,876
-2,981
-51% -$85K ﹤0.01% 2798
2018
Q4
$52K Sell
5,857
-4,526
-44% -$76.1K ﹤0.01% 2863
2018
Q3
$275K Sell
10,383
-46
-0.4% -$1.25K ﹤0.01% 2823
2018
Q2
$326K Buy
10,429
+3,012
+41% +$104K ﹤0.01% 2899
2018
Q1
$269K Buy
7,417
+5,226
+239% +$219K ﹤0.01% 2831
2017
Q4
$130K Buy
+2,191
New +$175K ﹤0.01% 2979
2017
Q3
Sell
-1,453
Closed -$156K 3325
2017
Q2
$156K Buy
+1,453
New +$174K ﹤0.01% 2832

Other funds holding CFMS

John Overdeck's CFMS Position: Q1 2022 in Review

John Overdeck sold out of Conformis, Inc. Common Stock (CFMS) in Q1 2022, closing a stake of 7,231 shares — an estimated $138K sold.

John Overdeck first reported a position in CFMS in Q2 2017 and held it in 13 quarters. The position peaked at $2.12M in Q3 2021. 85 funds tracked by Wall St. Rank hold CFMS as of Q1 2022.

  • John Overdeck reported no remaining Conformis, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • John Overdeck sold 7,231 Conformis, Inc. Common Stock shares in Q1 2022, an estimated $138K.
  • John Overdeck first reported a position in Conformis, Inc. Common Stock in Q2 2017 and held it in 13 quarters.
  • John Overdeck's Conformis, Inc. Common Stock position peaked at $2.12M in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.